Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Analysis of predictors for lactate elimination after reperfusion in recipients of living-donor liver transplantation.

Jun JH, Kim GS, Na YR, Gwak MS, Ko JS, Lee SK.

Transplant Proc. 2014 Apr;46(3):709-11. doi: 10.1016/j.transproceed.2013.11.090.

PMID:
24767330
2.
3.

Intraoperative blood lactate level as an early predictor of initial graft function in human living donor liver transplantation.

Nishimura A, Hakamada K, Narumi S, Totsuka E, Toyoki Y, Ishizawa Y, Umehara M, Yoshida A, Umehara Y, Sasaki M.

Transplant Proc. 2004 Oct;36(8):2246-8.

PMID:
15561207
4.

Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.

Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.

Liver Transpl. 2003 Jul;9(7):737-40.

5.

Negative prognostic impact of renal replacement therapy in adult living-donor liver transplant recipients: preoperative recipient condition and donor factors.

Iwata H, Mizuno S, Ishikawa E, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamamoto N, Sugimoto K, Shiraki K, Takei Y, Ito M, Isaji S.

Transplant Proc. 2014 Apr;46(3):716-20. doi: 10.1016/j.transproceed.2013.11.113.

PMID:
24767332
6.

Safety of small-for-size grafts in adult-to-adult living donor liver transplantation using the right lobe.

Moon JI, Kwon CH, Joh JW, Jung GO, Choi GS, Park JB, Kim JM, Shin M, Kim SJ, Lee SK.

Liver Transpl. 2010 Jul;16(7):864-9. doi: 10.1002/lt.22094.

7.

Graft size alone should not affect donors selection and be used to predict the prognosis of recipients after living donor liver transplantation.

Lei JY, Yan LN, Li B, Wen TF, Wang WT, Xu MQ, Yang JY.

Hepatogastroenterology. 2012 Jan-Feb;59(113):224-7. doi: 10.5754/hge11035.

PMID:
22260833
8.

Contribution of donor factors to post-reperfusion severe hyperglycemia in patients undergoing living donor liver transplantation.

Chung HS, Kim ES, Rho MC, Park CS.

Ann Transplant. 2015 Jun 3;20:303-11. doi: 10.12659/AOT.893648.

9.

A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.

Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR.

Liver Transpl. 2009 Dec;15(12):1776-82. doi: 10.1002/lt.21955.

10.
11.

Living donor liver transplantation with dual grafts -- a case report.

Botea F, Bra┼čoveanu V, Constantinescu A, Ionescu M, Matei E, Popescu I.

Chirurgia (Bucur). 2013 Jul-Aug;108(4):547-52.

12.

D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.

Ikegami T, Imai D, Wang H, Yoshizumi T, Yamashita Y, Ninomiya M, Iguchi T, Bekki Y, Shirabe K, Maehara Y.

Transplantation. 2014 Feb 27;97(4):457-62. doi: 10.1097/01.TP.0000435696.23525.d0.

PMID:
24531822
13.

Lower limit of the graft-to-recipient weight ratio can be safely reduced to 0.6% in adult-to-adult living donor liver transplantation in combination with portal pressure control.

Kaido T, Mori A, Ogura Y, Hata K, Yoshizawa A, Iida T, Yagi S, Uemoto S.

Transplant Proc. 2011 Jul-Aug;43(6):2391-3. doi: 10.1016/j.transproceed.2011.05.037.

PMID:
21839274
14.

Risk factors and criteria predicting early graft loss after adult-to-adult living donor liver transplantation.

Du Z, Wei Y, Chen K, Chen X, Zhang Z, Li H, Ma Y, Li B.

J Surg Res. 2014 Apr;187(2):673-82. doi: 10.1016/j.jss.2013.10.048. Epub 2013 Oct 29.

PMID:
24275573
15.

Adult-to-adult right-lobe living donor liver transplantation in recipients with hepatitis B virus-related benign liver disease and high model end-stage liver disease scores.

Jiang L, Yan L, Tan Y, Li B, Wen T, Yang J, Zhao J.

Surg Today. 2013 Sep;43(9):1039-48. doi: 10.1007/s00595-013-0539-z. Epub 2013 Mar 7.

PMID:
23467980
16.

Initial clinical effect of intraportal insulin administration on liver graft regeneration in adult patients underwent living donor right lobe liver transplantation.

Xu MQ, Yan LN, Li B, Wen TF, Zeng Y, Zhao JC, Wang WT, Yang JY, Ma YK, Chen ZY, Zhang ZW.

Transplant Proc. 2009 Jun;41(5):1698-702. doi: 10.1016/j.transproceed.2008.10.094.

PMID:
19545710
17.

Massive ascites after living donor liver transplantation with a right lobe graft larger than 0.8% of the recipient's body weight.

Shirouzu Y, Ohya Y, Suda H, Asonuma K, Inomata Y.

Clin Transplant. 2010 Jul-Aug;24(4):520-7. doi: 10.1111/j.1399-0012.2009.01117.x.

PMID:
19843111
18.

Emergent right lobe adult-to-adult living-donor liver transplantation for high model for end-stage liver disease score severe hepatitis.

Shi-Chun L, Meng-Long W, Ning L, Wei L, Ping C, Jin-Ning L, Jun D, Zhen Z, Ju-Shan W, Dong-Dong L, Qing-Liang G, Yue Z.

Transpl Int. 2010 Jan;23(1):23-30.

PMID:
20050081
19.

Risk factors of recipient receiving living donor liver transplantation in the comprehensive era of indication and perioperative managements.

Ishigami M, Katano Y, Hayashi K, Ito A, Hirooka Y, Onishi Y, Nakamura T, Kiuchi T, Goto H.

Nagoya J Med Sci. 2010 Aug;72(3-4):119-27.

PMID:
20942266
20.

Small-for-size graft in adult living-donor liver transplantation.

Lee HH, Joh JW, Lee KW, Kim SJ, Lee DS, Park JH, Choi SH, Heo JS, Hyon WS, Kwak MS, Lee SK.

Transplant Proc. 2004 Oct;36(8):2274-6.

PMID:
15561216

Supplemental Content

Support Center